Thomas Carella T2 Biosystems, Inc

As of December 11, 2015


Thomas Carella Net Worth

  • Net worth is estimated to be at least $1.07B
  • Owns at least 4,157,240 units of T2 Biosystems, Inc stock

Thomas Carella Trading

  • Largest purchase of shares was 3,457,240 units , worth over $10M on August 14, 2014
  • In total has made about 3 transactions over a year
  • Usually trades in December, August and June, with the busiest year in 2015
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Thomas Carella Mailing Address

  • Mailing address is C/o Goldman, Sachs & Co. 85 Broad Street New York NY 10004 NY

T2 Biosystems, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
John Sperzel, 2020 $490,705 - - $2,571,384 $393,750 $3,000 $3,458,839
John McDonough, 2020 $72,906 - $74,999 - - $1,022,182 $1,170,087
John McDonough, 2019 $550,000 - $372,000 $478,728 $233,750 $3,000 $1,637,478
Alec Barclay, 2020 $340,000 - $25,675 $38,621 $234,600 $952 $639,848
Alec Barclay, 2019 $337,500 $35,000 $111,600 $348,834 $102,000 $2,900 $937,834
Anthony Pare, 2020 $325,000 - $20,738 $159,763 $185,250 $3,000 $693,751
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm

T2 Biosystems, Inc Insider Trading

  • The most recent transaction was 61,988 units sold on January 10, 2022 by Aparna Ahuja worth over $29.75K
  • In the last 8 years, insiders at T2 Biosystems, Inc sold an estimated value of $8.91M and bought an estimated value of $60.72M
  • The most active traders are Thomas Lowery, Chief Scientific Officer,  David Elsbree, Director,  and John Sprague Attorney-In-Fact, Director
  • Insider trading is most common in June, with the busiest year in 2015

T2 Biosystems, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1